Properties of cytochrome P450 isoenzymes and their substrates Part 1: active site characteristics
- 1 October 1997
- journal article
- Published by Elsevier in Drug Discovery Today
- Vol. 2 (10) , 406-414
- https://doi.org/10.1016/s1359-6446(97)01081-7
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Molecular modelling of CYP3A4 from an alignment with CYP102: Identification of key interactions between putative active site residues and CYP3A-specific chemicalsXenobiotica, 1996
- Three-dimensional models of human and other mammalian microsomal P450s constructed from an alignment with P450102 (P450bm3)Xenobiotica, 1995
- Molecular modelling of members of the P4502A subfamily: application to studies of enzyme specificityXenobiotica, 1995
- Crystal structure and refinement of cytochrome P450terp at 2·3 Å resolutionJournal of Molecular Biology, 1994
- Correlation between site specificity and electrophilic frontier values in the metabolic hydroxylation of biphenyl, di-aromatic and CYP2D6 substrates: a molecular modelling studyXenobiotica, 1993
- The Human Hepatic Cytochromes P450 Involved in Drug MetabolismCritical Reviews in Toxicology, 1992
- The active site of cytochrome P-450 nifedipine oxidase: a model-building studyJournal of Molecular Graphics, 1989
- The molecular mechanisms of two common polymorphisms of drug oxidation-evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidationXenobiotica, 1986
- Physical Methods in the Study of the Active Site Geometry of Cytochromes P-450Drug Metabolism Reviews, 1986
- 7,8-Benzoflavone stimulates the metabolic activation of aflatoxin B1 to mutagens by human liverBiochemical and Biophysical Research Communications, 1978